The immune receptor triggering receptor expressed on myeloid cells-2 (TREM2) was recently identified as a genetic risk factor for AD (Guerreiro et al., 2013a, Jonsson et al., 2013). This evidence concerns the gene TREM2 and Alzheimer disease.